DOXGX | JCVVX | DOXGX / JCVVX | |
Total Expense Ratio | 0.41 | 0.84 | 49% |
Annual Report Gross Expense Ratio | 0.46 | 0.85 | 54% |
Fund Existence | 3 years | 16 years | - |
Gain YTD | 3.684 | 2.747 | 134% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 114B | 598M | 19,064% |
Annual Yield % from dividends | 1.49 | 2.93 | 51% |
Returns for 1 year | 6.03 | -27.40 | -22% |
Returns for 3 years | 28.44 | -29.20 | -97% |
Returns for 5 years | N/A | 7.56 | - |
Returns for 10 years | N/A | 0.25 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EKSRX | 6.02 | -0.02 | -0.33% |
Allspring Diversified Income Bldr R6 | |||
RYCFX | 40.37 | -0.38 | -0.93% |
Rydex Biotechnology C | |||
PREIX | 157.52 | -1.77 | -1.11% |
T. Rowe Price Equity Index 500 | |||
DNSMX | 21.13 | -0.32 | -1.49% |
Driehaus Small Cap Growth Institutional | |||
JGSMX | 20.88 | -0.39 | -1.83% |
JPMorgan Small Cap Growth R6 |